Calviks (CALVIK) Q2 2025 earnings summary

Executive summary

• Achieved significant strategic milestones in Q2 2025, including major acquisitions and a name change to support growth ambitions.

• Proforma revenue for H1 2025 reached 816,893 TSEK, up 356% year-over-year, reflecting the impact of recent acquisitions.

• Updated financial targets: aiming for 3 billion SEK in revenue and 120 MSEK EBITDA by 2028, with a leverage ratio below 3.0x.

• Maintained strong momentum despite challenging market conditions, leveraging a diversified structure and long-term client relationships.

Financial highlights

• Q2 2025 net sales: 416,481 TSEK (up 273.5% year-over-year); EBITDA: 12,758 TSEK (up 95.5%); operating income: 7,717 TSEK (up 46.3%).

• H1 2025 net sales: 534,218 TSEK (up 198.1%); EBITDA: 18,543 TSEK (up 30.3%); operating income: 12,281 TSEK (up 1.5%).

• Proforma H1 2025: net sales 816,893 TSEK (+356%), EBITDA 31,192 TSEK (+119%), operating income 20,702 TSEK (+71%).

• Q2 net income: 769 TSEK (down from 2,939 TSEK); EPS: 0.14 SEK (down from 0.57 SEK).

• Cash flow from operations in Q2: 7,304 TSEK; period-end cash: 90,556 TSEK.

Outlook and guidance

• Financial targets for 2028: 3 billion SEK in revenue, 120 MSEK EBITDA (4% margin), leverage below 3.0x.

• Continued focus on profitable growth, both organic and through strategic acquisitions.